IFF INTERNATIONAL FLAVORS & FRAGRANCES INC
Industrial Organic Chemicals · NYSE · SEC CIK 51253 · Fiscal year ends 12/31
Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters
Growth
TTM revenue YoY-1.9%
TTM net income YoY144.4%
TTM EPS YoY141.5%
Revenue 3-yr CAGR-7.4%
Net income 3-yr CAGR121.3%
Margins
Gross margin38.9%
Operating margin7.5%
Net margin2.1%
FCF margin5.4%
EBITDA margin14.3%
Returns
ROE1.4%
ROA0.8%
ROIC (approx.)2.8%
Asset turnover0.36x
Leverage & solvency
Liabilities / assets46.5%
Debt / equity0.47x
Current ratio1.87x
Interest coverage3.72x
Cash quality & payout
Operating cash flow / net income5.84x
Accruals ratio-3.7%
Payout ratio209.7%
Capex / revenue6.9%
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | 2026Q32026-09-30 | 2026Q22026-06-30 | 2026Q12026-03-31 | 2025Q4*2025-12-31 | 2025Q32025-09-30 | 2025Q22025-06-30 | 2025Q12025-03-31 | 2024Q4*2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||
| Revenue | $1.94B | $1.95B | $2.74B | $2.59B | $1.87B | $1.92B | $2.84B | $2.77B |
| Cost of revenue | $1.12B | $1.10B | $1.72B | $1.70B | $1.07B | $1.09B | $1.81B | $1.79B |
| Gross profit | $825.00M | $853.00M | $1.02B | $890.00M | $799.00M | $824.00M | $1.03B | $980.00M |
| R&D expense | $170.00M | $170.00M | $166.00M | $174.00M | $162.00M | $170.00M | $164.00M | $170.00M |
| SG&A expense | $387.00M | $437.00M | $427.00M | $469.00M | $348.00M | $409.00M | $461.00M | $517.00M |
| Operating income | $160.00M | $158.00M | $273.00M | $97.00M | $191.00M | $142.00M | -$903.00M | $127.00M |
| Interest expense | $46.00M | $46.00M | $44.00M | $49.00M | $48.00M | $61.00M | $71.00M | $69.00M |
| Pretax income | -$134.00M | $64.00M | $209.00M | -$1.07B | $130.00M | $438.00M | -$994.00M | -$115.00M |
| Income tax | -$7.00M | $31.00M | $39.00M | -$9.00M | $31.00M | -$112.00M | $23.00M | -$55.00M |
| Net income | -$55.00M | $50.00M | $169.00M | $31.00M | $40.00M | $599.00M | -$1.02B | -$60.00M |
| EBITDA | $238.00M | $230.00M | $519.00M | $334.00M | $258.00M | $206.00M | -$667.00M | $370.00M |
| EPS (basic) | -0.22 | 0.20 | 0.66 | — | 0.16 | 2.34 | -3.98 | — |
| EPS (diluted) | -0.22 | 0.20 | 0.66 | — | 0.16 | 2.33 | -3.98 | — |
| Dividends declared per share | 0.40 | 0.40 | 0.40 | 0.40 | 0.40 | 0.40 | 0.40 | 0.40 |
| Weighted avg. shares (diluted) | 253.00M | 257.00M | 257.00M | — | 257.00M | 257.00M | 256.00M | — |
| Balance sheet | ||||||||
| Cash & equivalents | $272.00M | $569.00M | $562.00M | $347.00M | $399.00M | $816.00M | $613.00M | $312.00M |
| Receivables | $1.42B | $1.42B | $1.83B | $1.29B | $1.87B | $1.80B | $1.74B | $1.62B |
| Inventory | $1.45B | $1.50B | $2.25B | $1.51B | $2.32B | $2.37B | $2.25B | $2.13B |
| Current assets | $9.28B | $9.09B | $5.44B | $5.59B | $5.88B | $5.93B | $8.63B | $7.97B |
| PP&E, net | $2.65B | $2.67B | $4.00B | $2.69B | $3.87B | $3.90B | $3.77B | $3.74B |
| Goodwill | $8.08B | $8.14B | $8.22B | $8.23B | $8.26B | $8.28B | $8.03B | $9.07B |
| Intangibles | $3.47B | $3.73B | $5.87B | $3.96B | $6.18B | $6.43B | $6.38B | $6.45B |
| Total assets | $24.82B | $25.15B | $25.14B | $25.54B | $25.77B | $26.12B | $28.27B | $28.72B |
| Current liabilities | $4.96B | $4.41B | $3.65B | $3.93B | $4.07B | $3.18B | $4.61B | $4.35B |
| Short-term debt | $1.54B | $964.00M | $1.08B | $1.25B | $1.31B | $500.00M | $1.69B | $1.41B |
| Long-term debt | $4.74B | $4.74B | $4.74B | $4.74B | $4.74B | $5.68B | $7.60B | $7.56B |
| Total debt | $6.27B | $5.70B | $5.82B | $5.99B | $6.05B | $6.18B | $9.29B | $8.98B |
| Total liabilities | $11.54B | $11.14B | $10.99B | $11.35B | $11.48B | $11.74B | $15.09B | $14.85B |
| Shareholders' equity | $13.26B | $13.98B | $14.12B | $14.15B | $14.24B | $14.40B | $13.18B | $13.83B |
| Net debt | $6.00B | $5.13B | $5.25B | $5.64B | $5.65B | $5.37B | $8.68B | $8.66B |
| Shares outstanding | 250.40M | 255.30M | 255.20M | 255.70M | 256.30M | 256.30M | 255.70M | 255.70M |
| Cash flow statement | ||||||||
| Operating cash flow | $141.00M | $422.00M | $257.00M | $318.00M | $164.00M | $241.00M | $127.00M | $368.00M |
| Capital expenditure | $148.00M | $136.00M | $165.00M | $188.00M | $132.00M | $95.00M | $179.00M | $160.00M |
| Free cash flow | -$7.00M | $286.00M | $92.00M | $130.00M | $32.00M | $146.00M | -$52.00M | $208.00M |
| Investing cash flow | -$141.00M | -$156.00M | $23.00M | -$157.00M | -$115.00M | $2.70B | -$157.00M | -$260.00M |
| Financing cash flow | -$44.00M | -$264.00M | -$301.00M | -$200.00M | -$237.00M | -$2.82B | $169.00M | -$162.00M |
| Depreciation & amortization | $78.00M | $72.00M | $246.00M | $237.00M | $67.00M | $64.00M | $236.00M | $243.00M |
| Stock-based compensation | $18.00M | $33.00M | $16.00M | $16.00M | $19.00M | $30.00M | $19.00M | $18.00M |
| Dividends paid | $102.00M | $102.00M | $102.00M | $103.00M | $102.00M | $102.00M | $102.00M | $103.00M |
| Share buybacks | $513.00M | $36.00M | $35.00M | $38.00M | $0 | $0 | $0 | — |
Free plan shows the latest 8 periods; Pro shows all 70 🔒
· Most companies do not report Q4 separately: Q4 = full year − first three quarters (marked *). EPS and share counts cannot be subtracted, so Q4 EPS is often blank; cash flow statements are year-to-date in quarterly reports, so single quarters are mostly derived.
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-20 06:27.